368 results on '"Awada, Hussein"'
Search Results
2. Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis—insights from a multicenter study: CHRONIC MYELOPROLIFERATIVE NEOPLASMS
3. Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy
4. Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting
5. Clonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders
6. Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysis
7. Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study
8. Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study
9. Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis
10. Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia
11. Molecular patterns identify distinct subclasses of myeloid neoplasia
12. High-grade large cell neuroendocrine carcinoma of the esophagus: a case report and review of the literature
13. Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting
14. Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M
15. A multimodal analysis of genomic and RNA splicing features in myeloid malignancies
16. Validation of the CIBMTR scoring system in predicting early relapse of multiple myeloma after autologous hematopoietic cell transplant
17. Mantle cell lymphoma negative for t(11,14) involving the kidneys: a case report
18. Knowledge, attitudes, and practices regarding drug interactions among community pharmacists
19. Assessing the combination of magnetic field stimulation, iron oxide nanoparticles, and aligned electrospun fibers for promoting neurite outgrowth from dorsal root ganglia in vitro
20. Synergistic effect of concurrent high molecular risk mutations and lower JAK2mutant variant allele frequencies on prognosis in patients with myelofibrosis—insights from a multicenter study
21. Non canonical c-CBLmutations define a specific phenotype of myeloid neoplasia
22. Thrombocytosis and megakaryocyte changes associated with PRCA
23. Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia
24. Efficacy and Safety of Idecabtagene Vicleucel (ide-cel) in Patients with Relapsed-Refractory Multiple Myeloma (RRMM) Not Meeting the Karmma-1 Trial Eligibility Criteria: A Real-World Multicenter Study from the US Myeloma Innovations Research Collaborative (USMIRC)
25. Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report
26. Molecular organization relationship of low-bandgap polymers at the air-water interface and in solid films
27. Surface engineering of ITO electrode with a functional polymer for PEDOT:PSS-free organic solar cells
28. Early postoperative recovery after peri-acetabular osteotomy: A double-blind, randomised single-centre trial of 48 vs. 8 mg dexamethasone
29. Validation of the GATMO score in predicting non‐relapse mortality following hematopoietic cell transplant in multiple myeloma patients
30. P726: TET2 ALLELIC BURDEN IMPRINTS A CONTEXT-DEPENDENT PROGNOSTIC SIGNIFICANCE OF ASXL1 MUTATION IN CHRONIC MYELOMONOCYTIC LEUKAEMIA
31. Dexamethasone Dose and Early Postoperative Recovery after Mastectomy: A Double-blind, Randomized Trial
32. Endocrinopathies from checkpoint inhibitors: Incidence, outcomes, and management
33. Continuous monitoring is superior to manual measurements in detecting vital sign deviations in patients with COVID-19
34. Azido‐Functionalized Fullerenes, Perylenediimide, Perylene and Tetraphenylethylene as Crosslinkers for Applications in Materials Science
35. What’s Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach
36. Validation of the role of corrected DLCO in predicting outcomes post autologous hematopoietic cell transplant for Multiple Myeloma
37. Continuous monitoring is superior to manual measurements in detecting vital sign deviations in patients with COVID‐19
38. Novel Scheme for Defining the Clinical Implications of TP53 Mutations in Myeloid Neoplasia
39. The Heterogeneous Complexity of Myeloid Neoplasm: Multi-Level Approaches to Study the Disease
40. The Characteristics of Multiple Myeloma Patients Referred for CAR T-Cell Therapy
41. Incidence of Venous Thromboembolism in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplant
42. Factors That Predict Early Relapse Post Autologous Hematopoietic Cell Transplant in Multiple Myeloma Patients
43. Analysis of Factors That Predict Progression Free and Overall Survival Post Autologous Hematopoietic Cell Transplant in Multiple Myeloma Patients
44. Outcomes of CMV Infection in the Setting of Gastrointestinal Graft Vs. Host Disease in the Era of Pre-Emptive and Prophylactic Antiviral Therapy
45. Infectious Complications Following CAR T-Cell Therapy in Patients with Relapsed and Refractory Multiple Myeloma
46. Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia
47. Days alive and out of hospital following primary surgery for oral cavity squamous cell carcinoma
48. The status of bladder cancer research worldwide, a bibliometric review and recommendations
49. Risk of Venous Thromboembolism in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplant
50. Dead and Deah-Box Helicases Other Than DDX41 Are Mutated in Myeloid Neoplasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.